Robin Wright

Group Chief Financial Officer at MiNA Therapeutics

Robin was appointed Chief Financial Officer in 2021. He has over three decades of experience in over 250 financing transactions and 170 M&A transactions, with previous CFO roles at listed biopharmaceutical companies Pharming Group NV, Karolinska Development AB and Orexo AB. Prior to this, Robin held senior roles in private equity and investment banking, including Head of European Pharma & Chemicals M&A at Citibank Salomon Smith Barney. He is a Fellow of the Institute of Chartered Accountants in England and Wales. Robin is also non-executive chairman of Vaccitech.

Links


Org chart